| Current price reference | $76.46 at the August 3, 2026 market open reading, up 2.14% from the $74.86 July 31 close, after opening at $75.88 | StockAnalysis.com real-time quote | August 3, 2026 |
| Market capitalization | $5.67 billion, computed as $76.46 x 74.21 million shares and reported by StockAnalysis.com | StockAnalysis.com quote and statistics | August 3, 2026 |
| Shares outstanding | 74.21 million shares outstanding as of July 15, 2026, per the Q2 2026 Form 10-Q cover and StockAnalysis.com, down about 3.25% year over year | Q2 2026 Form 10-Q and StockAnalysis.com statistics | August 3, 2026 |
| Q2 2026 net revenues | $375 million, down 6% from $397 million, reflecting the absence of pass-through revenue from the May 2025 global franchisee conference, lower other franchise fees, and the deferral of Revo fees, partially offset by higher ancillary revenues and 4% net room growth excluding Revo | Wyndham Q2 2026 earnings release | July 22, 2026 |
| Q2 2026 net income and adjusted net income | Net income of $102 million up 17% from $87 million, adjusted net income of $111 million up 8% from $103 million and flat on a comparable basis | Wyndham Q2 2026 earnings release | July 22, 2026 |
| Q2 2026 EPS | Diluted EPS of $1.36 up 20% from $1.13, adjusted diluted EPS of $1.48 up 11% from $1.33 and about 3% higher on a comparable basis | Wyndham Q2 2026 earnings release | July 22, 2026 |
| Q2 2026 adjusted EBITDA | $212 million up 9% from $195 million, or 3% higher on a comparable basis excluding marketing fund variability | Wyndham Q2 2026 earnings release and earnings call | July 22, 2026 |
| Q2 2026 RevPAR | U.S. RevPAR of $54.50 up 2%, International RevPAR of $37.31 down 6%, Global RevPAR of $47.01 down 1% in constant currency | Wyndham Q2 2026 earnings release | July 22, 2026 |
| Q2 2026 regional RevPAR detail | U.S. Midscale and Upper Midscale RevPAR of $62.36 up 3%, U.S. Economy $43.48 up 1%, U.S. Upscale and Above $91.85 down 5%, Canada $61.49 up 2%, Greater China $16.43 down 5%, Rest of Asia Pacific $28.78 up 5%, EMEA $57.19 down 6%, Latin America $50.99 down 7%, with Middle East RevPAR down 45% | Wyndham Q2 2026 earnings release | July 22, 2026 |
| System size and pipeline | 873,400 global rooms at June 30, 2026, up 3%, or 853,600 rooms up 4% excluding Revo; development pipeline of approximately 261,000 rooms and over 2,200 hotels, up 4% excluding Revo to a record, carrying a FeePAR premium of about 30%; record Q2 openings of nearly 18,000 rooms up 7% year over year | Wyndham Q2 2026 earnings release | July 22, 2026 |
| 2026 full-year outlook | Net revenues of $1.48 billion to $1.50 billion, adjusted EBITDA of $735 million to $745 million, adjusted net income of $355 million to $365 million, adjusted diluted EPS of $4.71 to $4.83, global RevPAR growth of 0.0% to 1.0%, net room growth of 4.0% to 4.5%, and a 55% to 60% free cash flow conversion rate | Wyndham Q2 2026 earnings release | July 22, 2026 |
| Q2 2026 cash flow and capital returns | Net cash provided by operating activities of $91 million up 30%, adjusted free cash flow of $105 million up 19%, $86 million returned to shareholders including $54 million of share repurchases for about 657,000 shares and $32 million of dividends at $0.43 per share; year to date, $169 million of free cash flow, $170 million returned, and 1.3 million shares repurchased for $105 million | Wyndham Q2 2026 earnings release and earnings call | July 22, 2026 |
| Balance sheet | Cash of $69 million, total debt of $2.675 billion, net debt of $2.606 billion, net leverage of 3.5x at the midpoint of the 3x to 4x target, total liquidity of about $1.0 billion, and total equity of $480 million as of June 30, 2026, matching SEC EDGAR XBRL | Q2 2026 Form 10-Q, Wyndham Q2 2026 earnings release, and SEC EDGAR XBRL | August 3, 2026 |
| FY2025 financials | FY2025 revenue of $1.43 billion up 1.78% from $1.40 billion, net income of $193 million down 33.22% from $289 million, adjusted EBITDA of $718 million, with Q4 2025 including an $86 million impairment and $74 million of Revo-related charges | Wyndham FY2025 Form 10-K and StockAnalysis.com | August 3, 2026 |
| TTM financials | TTM revenue of $1.42 billion, TTM net income of $207 million, TTM EPS of $2.74, TTM gross profit of $891 million, TTM operating income of $533 million, TTM EBITDA of $527 million, and TTM free cash flow of $323 million, or $4.35 per share | StockAnalysis.com statistics | August 3, 2026 |
| Valuation check | 27.36 trailing PE, 15.32 forward PE, 3.92 price to sales, 17.20 price to free cash flow, 15.49 EV to EBITDA, 25.27 EV to FCF, 11.70 price to book, and a 2.30% dividend yield per StockAnalysis.com; exact decimal math on the same figures gives about 27.91x trailing, 4.00x sales, 17.58x price to FCF, and 2.25% yield at the $76.46 reading | StockAnalysis.com statistics and financial_rigor.py | August 3, 2026 |
| Analyst consensus | Buy with an average 12-month price target of $98.47 across 17 analysts, low of $80, high of $115, and median of $98, about 28.79% above the $76.46 price | StockAnalysis.com forecast | July 29, 2026 |
| Analyst rating mix, July 2026 | 10 Strong Buy, 4 Buy, 3 Hold, 0 Sell, 0 Strong Sell out of 17 analysts | StockAnalysis.com forecast recommendation trends | July 29, 2026 |
| Recent analyst target updates | J.P. Morgan $97 to $95 on July 29, Wells Fargo $98 to $87 on July 24, Goldman Sachs $87 to $80 on July 23, Morgan Stanley $89 to $93 on July 23, Truist maintained Buy on July 23, with earlier updates from J.P. Morgan, Barclays, Wells Fargo, Susquehanna, and Morgan Stanley | StockAnalysis.com forecast and news feed | July 29, 2026 |
| Short interest | 7.30 million shares short, 9.83% of shares outstanding, 9.99% of float, and 4.96 days to cover | StockAnalysis.com statistics short selling | August 3, 2026 |
| 52-week range and performance | 52-week range of $69.21 to $91.44, 52-week price change of about negative 15.3%, and beta of 0.63 | StockAnalysis.com quote and statistics | August 3, 2026 |
| Dividend | Annual dividend of $1.72 per share with a 2.30% yield, quarterly dividend of $0.43 per share, dividend growth of about 6.33% year over year, five years of dividend growth, and a payout ratio of about 62.86% | StockAnalysis.com dividend history and Wyndham dividend press release | August 3, 2026 |
| Financial forecast | FY2026 revenue estimate of $1.48 billion up 3.41%, FY2026 adjusted EPS estimate of $4.79 up 4.63%, FY2027 revenue estimate of $1.57 billion, and FY2027 adjusted EPS estimate of $5.34 | StockAnalysis.com forecast | July 29, 2026 |
| Revo insolvency | Revo, a large European franchisee, filed for insolvency in early 2026. Wyndham removed all Revo-related revenue from reported results and outlook, deferred about $12 million of royalties and franchise fees from Revo, excluded Revo rooms from net room growth, expects most of the Revo portfolio to terminate during the third and fourth quarter of 2026, expects to retain a subset and sign new franchise agreements with new operators, and recognized about $10 million of net revenue from two Revo hotels it took possession of | Wyndham Q2 2026 earnings release and earnings call | July 22, 2026 |
| Growth algorithm | Long-term algorithm of high single digit adjusted EBITDA growth on 2% to 3% RevPAR growth and 4% to 5% net room growth, with ancillary revenue growing low double digits this year and high single digits long term, and royalty rate up 5 basis points annually | Wyndham Q2 2026 earnings call | July 23, 2026 |
| Technical snapshot | 5-day SMA near $75.61, 20-day SMA near $76.74, 50-day SMA near $79.94 to $80.04, 100-day SMA near $80.87, 200-day SMA near $78.68 to $78.70, 14-day RSI near 39.6 to 43.4, 14-day ADX near 20.33, 14-day historical volatility near 24.23%, and 20-day average volume near 1.33 million to 1.40 million shares | Barchart and StockAnalysis.com technical snapshots | August 3, 2026 |
| Credit scores | Altman Z-Score of 1.87 and Piotroski F-Score of 5 | StockAnalysis.com statistics | August 3, 2026 |